CIBC Private Wealth Group
RIGL icon

CIBC Private Wealth Group’s Rigel Pharmaceuticals RIGL Stock Holding History

CIBC Private Wealth Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.42K Buy
+150
New +$5.65K ﹤0.01% 2567

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC Private Wealth Group's RIGL Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Rigel Pharmaceuticals (RIGL) in Q4 2025: 150 shares worth $6.42K. The stake represents ﹤0.01% of the portfolio and ranks #2567 among its holdings.

193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.

  • CIBC Private Wealth Group held 150 shares of Rigel Pharmaceuticals worth $6.42K as of Q4 2025.
  • Rigel Pharmaceuticals was a new CIBC Private Wealth Group position in Q4 2025.
  • Rigel Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2567 holding.
  • 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.